Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Predictive Oncology Inc (NQ: POAI )

1.380 -0.490 (-26.20%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 26, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 6,015,393
Open 1.480
Bid (Size) 1.280 (79)
Ask (Size) 1.300 (2)
Prev. Close 1.870
Today's Range 1.210 - 1.545
52wk Range 0.8940 - 5.940
Shares Outstanding 4,063,081
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Why Saia Shares Are Trading Lower? Here Are Other Stocks Moving In Friday's Mid-Day Session
Via Benzinga
AINewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Enters into $1.2M Agreement for Exercise of Warrants
Via Investor Brand Network
Topics Artificial Intelligence
Exposures Artificial Intelligence

Performance

YTD
-60.85%
-60.85%
1 Month
+30.19%
+30.19%
3 Month
-8.61%
-8.61%
6 Month
-55.05%
-55.05%
1 Year
-73.05%
-73.05%

More News

Read More
Why Is Predictive Oncology (POAI) Stock Up 70% Today?
Via InvestorPlace
Predictive Oncology Announces Exercise of Warrants for $1.26 Million Gross Proceeds
From Predictive Oncology Inc.
Via GlobeNewswire
Why Edwards Lifesciences Shares Are Trading Lower? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
Why Predicitive Oncology Stock Is Soaring
Via Benzinga
Topics Artificial Intelligence
Exposures Artificial Intelligence
Nasdaq Gains 1%; American Airlines Cuts Earnings Forecast
Via Benzinga
Dow Jumps 200 Points; Honeywell Trims Profit Outlook
Via Benzinga
Topics Stocks
Exposures US Equities
InvestorNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Expands Its AI/ML Driven Platform to Include Novel Oncology Biomarker Discovery
Via Investor Brand Network
Topics Artificial Intelligence
Exposures Artificial Intelligence
Predictive Oncology Enters Biomarker Discovery Market After Successful Retrospective Ovarian Cancer Study Yields Compelling Results
From Predictive Oncology Inc.
Via GlobeNewswire
7 F-Rated Growth Stocks to Avoid Right Now: June 2024
Via InvestorPlace
InvestorNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Unveils Novel Technology, Eyes Significant Partnership Opportunities
Via Investor Brand Network
Topics Artificial Intelligence Intellectual Property
Exposures Artificial Intelligence Intellectual Property
Predictive Oncology Develops Novel Stem Cell Expression System for the Production of Functional and Stable G-Protein Coupled Receptors (GPCRs)
From Predictive Oncology Inc.
Via GlobeNewswire
InvestorNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Launches Novel Technology to Accelerate Cancer Drug Discovery, Development
Via Investor Brand Network
Topics Animal Testing Artificial Intelligence
Exposures Animal Testing Artificial Intelligence
Predictive Oncology Launches Novel 3D Cell Technology to Accelerate Cancer Therapeutic Drug Discovery
From Predictive Oncology Inc.
Via GlobeNewswire
TinyGemsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) CEO to Participate at Upcoming BIO International Convention 2024
Via Investor Brand Network
Topics Artificial Intelligence
Exposures Artificial Intelligence
Why Bank of Montreal Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
Why Ooma Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Predictive Oncology Announces CEO Raymond Vennare to Present at the BIO International Convention 2024
From Predictive Oncology Inc.
Via GlobeNewswire
Why Applied DNA Sciences Shares Are Trading Lower By Around 68%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Why Predictive Oncology (POAI) Stock Is Skyrocketing
Via Benzinga
TinyGemsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Announces Positive Results from Ovarian Cancer Study
Via Investor Brand Network
Topics Artificial Intelligence
Exposures Artificial Intelligence
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Predictive Oncology Announces Positive Results from Ovarian Cancer Study with UPMC Magee-Womens Hospital to be Presented at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
From Predictive Oncology Inc.
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.